Also trades as: 4553.T (JPX) · $vol 3M
TWAPF OTC
Towa Pharmaceutical Co., Ltd.
1W: +0.0%
1M: -1.0%
3M: +52.9%
YTD: +52.9%
1Y: +inf%
3Y: +8.7%
5Y: -48.2%
$25.98
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$30.6B
+30.9% ▲
5Y CAGR: +20.6%
Capital Expenditures
$22.4B
+28.2% ▲
5Y CAGR: +17.8%
Free Cash Flow
$8.2B
+204.9% ▲
5Y CAGR: +31.0%
Dividends Paid
$4.0B
-34.2% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2.8B
-117.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $22.2B | $4.6B | $16.2B | $26.3B | $5.3B |
| Depreciation & Amort. | $11.0B | $19.4B | $17.9B | $20.1B | $23.0B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$3.1B | -$13.7B | -$32.6B | -$3.9B | -$6.6B |
| Other Non-Cash Items | -$8.0B | -$7.7B | $6.7B | -$19.1B | $9.0B |
| Operating Cash Flow | $22.1B | $2.5B | $8.2B | $23.4B | $30.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$13.6B | -$30.5B | -$37.9B | -$28.7B | -$24.3B |
| Acquisitions (Net) | -$45.4B | -$1.5B | -$1.6B | $0 | $13M |
| Investment Purchases | -$1M | -$301M | -$50M | -$203M | -$1.5B |
| Investment Sales | $18M | $34M | $0 | $0 | $0 |
| Other Investing | -$765M | $1.9B | -$923M | -$2.3B | -$53M |
| Investing Cash Flow | -$59.7B | -$30.3B | -$40.4B | -$31.3B | -$25.8B |
| — Financing Activities — | |||||
| Net Debt Issuance | $49.1B | $20.9B | $38.6B | $15.4B | -$2.9B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$2.4B | -$3.1B | -$3.0B | -$3.0B | -$4.0B |
| Other Financing | -$184M | -$302M | -$201M | $9.1B | $38M |
| Financing Cash Flow | $46.5B | $17.5B | $35.4B | $21.6B | -$6.9B |
| Net Change in Cash | $9.9B | -$8.6B | $5.4B | $15.8B | -$2.8B |
| Cash End of Period | $32.8B | $24.3B | $29.6B | $45.5B | $45.6B |
| Free Cash Flow | $8.6B | -$27.9B | -$31.1B | -$7.8B | $8.2B |